North York, Canada

Jeffrey A Medin

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • North York, CA (2013 - 2019)
  • Shorewood, WI (US) (2018 - 2023)

Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey A. Medin

Introduction

Jeffrey A. Medin is a prominent inventor based in North York, Canada, known for his significant contributions to the field of immunotherapy and gene therapy. With a total of 10 patents to his name, Medin has made remarkable strides in developing novel treatments for various malignancies and disorders.

Latest Patents

Among his latest patents, Medin has developed bispecific antibodies targeting human CD30, which are instrumental in the immunotherapy of CD30+ malignancies. This invention provides innovative methods for treating cancer using these bispecific antibodies. Additionally, he has created an enrichment strategy targeting lymphocytes derived from vector-transduced hematopoietic stem cells (HSCs) for the therapy of disorders. This invention involves a dual promoter lentiviral vector and outlines methods for treating diseases, particularly lysosomal storage disorders.

Career Highlights

Throughout his career, Jeffrey A. Medin has worked with esteemed institutions such as the University Health Network and The Medical College of Wisconsin, Inc. His work has significantly impacted the medical community, particularly in the areas of cancer treatment and genetic disorders.

Collaborations

Medin has collaborated with notable professionals in his field, including Christopher J. Paige and Sean Devine. These collaborations have further enhanced the development and application of his innovative inventions.

Conclusion

Jeffrey A. Medin's contributions to the fields of immunotherapy and gene therapy exemplify the impact of innovation in medicine. His patents and collaborations continue to pave the way for advancements in treating complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…